To investigate the effect of MYC K412 methylation on bladder tumor growth, we mutated the endogenous MYC K412 into arginine in HT1197 cells using CRISPR‐cas9 gene editing (Figure S4a,b, Supporting Information). Here, MYC is linked to urinary bladder neoplasm.